Fulgent Genetics, Inc.

Healthcare

NASDAQ:FLGT · NASDAQ Global Market

Market Cap $511.21M Beta 0.92 P/E (TTM) -7.5

$18.00 +1.89%

+$0.33 today

52W Low $13.46High $31.04

Vol 0.66M · Avg 0.55M

EPS (TTM) -$2.39Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-6.88%

Period High

$30.85

Period Low

$13.79

Latest

$18.00

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Butterfly Network, Inc.

NYSE:BFLY

$1.96B

CareDx, Inc

NASDAQ:CDNA

$1.28B

Personalis, Inc.

NASDAQ:PSNL

$880.94M

Castle Biosciences, Inc.

NASDAQ:CSTL

$617.82M

Valneva SE

NASDAQ:VALN

$508.25M

Arvinas, Inc.

NASDAQ:ARVN

$488.43M

Pacific Biosciences of California, Inc.

NASDAQ:PACB

$427.08M

Myriad Genetics, Inc.

NASDAQ:MYGN

$424.07M

Anavex Life Sciences Corp.

NASDAQ:AVXL

$243.26M

DarioHealth Corp.

NASDAQ:DRIO

$51.26M

What is the latest FLGT filing?

The latest filing shown is 8-K dated Jun 2, 2026.

How many recent filings does FLGT have?

Intrinsic Alpha currently shows 20 recent filings for FLGT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.